Name of Trial | Description |
The Gilead – DIVERSITY Study | A study to evaluate the efficacy and safety of the orally administered drug Filgotinib for the treatment of active Crohn’s disease. |
Creatine Supplementation Study | A study to evaluate dietary creatine supplementation for the reduction of mucosal inflammation through improved epithelial barrier function of active Ulcerative colitis. |
AbbVie M20-371 AIM-CD (22-0136) | A Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD). |
Please contact Gianna Morales for more information:
Email: gianna.morales@cuanschutz.edu